Importance Platelets represent a potential therapeutic target for improved clinical outcomes
in patients with COVID-19. Objective To evaluate the benefits and risks of adding a P2Y12 …

Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …

Background The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind
(DB) study extended understanding of the efficacy of benralizumab for patients with …

Background and objective The predictive Khorana's model was developed to score the
thromboembolic disease risk in cancer patients on chemotherapy and to identify which patients …

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare but potentially life-threatening
antineutrophil cytoplasmic antibodyeassociated vasculitis that affects, to varying degrees, …

Introduction Randomized clinical trials have demonstrated non-inferiority of rivaroxaban
compared with vitamin K antagonists (VKAs) in the treatment of venous thromboembolism (VTE)…

… Raquel Morillo Guerrero has received honorariafor speaking engagements and travel and
accommodation expenses from Pfizer, Menarini, and GSK, unrelated to this manuscript. The …

Fundamento y objetivo El modelo predictivo de Khorana se desarrolló para estratificar el
riesgo de enfermedad tromboembólica en pacientes con cáncer y en tratamiento con …

Background Therapeutic-dose heparin decreased days requiring organ support in noncritically
ill patients hospitalized for COVID-19, but its impact on persistent symptoms or quality of …

… Raquel Morillo Guerrero ha recibido honorarios como ponente o en concepto de traslado
y alojamiento por parte de PFIZER, Menarini y GSK, independientemente del manuscrito …